CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02171 CARSGEN-B

Market Closed 02-20 16:08:38

15.620

+0.550

+3.65%

High15.790	Low14.600	Vol2.30M
Open15.070	D1 Closing15.070	Amplitude7.90%
Mkt Cap8.90B	Tradable Cap8.90B	Total Shares570.00M
T/O35.47M	T/O Rate0.40%	Tradable Shares570.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"CARSGEN-B","latestPrice":15.62,"timestamp":1771574918003,"preClose":15.07,"halted":0,"volume":2303000,"delay":0,"changeRate":0.03649635036496343,"floatShares":570000000,"shares":570000000,"eps":-1.443602,"marketStatus":"Market Closed","change":0.55,"latestTime":"02-20 16:08:38","open":15.07,"high":15.79,"low":14.6,"amount":35470179,"amplitude":0.078965,"askPrice":15.66,"askSize":18500,"bidPrice":15.62,"bidSize":67500,"shortable":3,"etf":0,"ttmEps":-1.040003,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771810200000},"marketStatusCode":7,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.07,"openAndCloseTimeList":[[1771551000000,1771560000000],[1771563600000,1771574400000]],"volumeRatio":2.1991035757827446,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171","defaultTab":"news","newsList":[{"id":"2612310744","title":"Assessing CARsgen Therapeutics Holdings’ Valuation After New CAR T-Cell Manufacturing Cooperation News","url":"https://stock-news.laohu8.com/highlight/detail?id=2612310744","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612310744?lang=en_us&edition=fundamental","pubTime":"2026-02-17 10:18","pubTimestamp":1771294682,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) has signed cooperation agreements via its subsidiary CARsgen Diagnostics with Shanghai Jingong Enterprise to build a commercial CAR T-cell manufacturing base in Shanghai, a move closely linked to its commercialization plans.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe cooperation news comes as momentum in CARsgen Therapeutics Holdings' share price has recently picked up, with a 1-day share price return of 4.65% and a 7-day share...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/assessing-carsgen-therapeutics-holdings-valuation-after-new","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/assessing-carsgen-therapeutics-holdings-valuation-after-new","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","02171","BK1574","BK1161","BK1587","BK1585","BK4007","BK4022","LENZ","CAR","BK4539","BK4230"],"gpt_icon":0},{"id":"2611638189","title":"High Growth Tech Stocks In Asia With Promising Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2611638189","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611638189?lang=en_us&edition=fundamental","pubTime":"2026-02-13 12:08","pubTimestamp":1770955683,"startTime":"0","endTime":"0","summary":"As global markets experience volatility with mixed results across major indices, the focus has shifted towards small-cap and value-oriented stocks, which have shown resilience amidst concerns over artificial intelligence investments and geopolitical tensions. In this dynamic environment, identifying promising high-growth tech stocks in Asia requires a keen understanding of market trends and economic indicators that can influence their potential for growth.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/high-growth-tech-stocks-in-asia-with-promising-potential-39","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/high-growth-tech-stocks-in-asia-with-promising-potential-39","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1585","BK1574","BK1161","02171","BK1587"],"gpt_icon":0},{"id":"2611390143","title":"CARsgen Signs Strategic Cooperation Agreements to Expand CAR-T Commercial Manufacturing Base in Jinshan, Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2611390143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611390143?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:15","pubTimestamp":1770941700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nTUA5MSHHF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1161","02171","BK1585","BK1574"],"gpt_icon":0},{"id":"1184734887","title":"CARSGEN-B Forges Strategic Partnership to Establish Commercial CAR-T Production Facility in Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=1184734887","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184734887?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:10","pubTimestamp":1770941425,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that on February 12, 2026 (after trading hours), its indirectly wholly-owned subsidiary, Shanghai Kaixing Diagnostic Technology, entered into a strategic cooperation...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","BK1161","159830","02171","BK4022","BK1574","BK1585","CAR","BK1587"],"gpt_icon":0},{"id":"2611901984","title":"BRIEF-CARsgen Therapeutics Entering Into Strategic Cooperation Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2611901984","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611901984?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:06","pubTimestamp":1770941160,"startTime":"0","endTime":"0","summary":"BRIEF-CARsgen Therapeutics Entering Into Strategic Cooperation AgreementsFeb 13  - CARsgen Therapeutics Holdings Ltd 2171.HK:ENTERING INTO STRATEGIC COOPERATION AGREEMENTSCO WILL ESTABLISH ADVANCED COMMERCIAL MANUFACTURING BASE FOR CAR T-CELL PRODUCTS IN JINSHAN DISTRICT, SHANGHAIINVESTMENT OF RMB370 MLN FOR MANUFACTURING BASE IN SHANGHAIFurther company coverage: 2171.HK ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1161","BK1585","BK1587","BK1574"],"gpt_icon":0},{"id":"2611015739","title":"CARsgen Therapeutics Invests Up to RMB370 Million in Shanghai CAR T-Cell Manufacturing Base","url":"https://stock-news.laohu8.com/highlight/detail?id=2611015739","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611015739?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:00","pubTimestamp":1770940847,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Ltd. announced that it has entered into Strategic Cooperation Agreements through its wholly-owned subsidiary to establish an advanced commercial manufacturing base for CAR T-cell products in Jinshan District, Shanghai, with a total investment not exceeding RMB370 million. The transaction constitutes a disclosable transaction under Hong Kong Listing Rules, requiring reporting and announcement but not shareholder approval.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 13, 2026, and is solely responsible for the info","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDLbJxgNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1161","BK1585","BK1574","BK1587"],"gpt_icon":0},{"id":"2611901543","title":"CARsgen Therapeutics  - Investment of RMB370 Mln for Manufacturing Base in Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2611901543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611901543?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:00","pubTimestamp":1770940846,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81DT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","BK1574","02171","BK1587","BK1161"],"gpt_icon":0},{"id":"2611901545","title":"CARsgen Therapeutics Holdings Ltd - Entering Into Strategic Cooperation Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2611901545","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611901545?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:00","pubTimestamp":1770940835,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81IQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","BK1161","02171","BK1574","BK1587"],"gpt_icon":0},{"id":"2611901503","title":"CARsgen Therapeutics - Co Will Establish Advanced Commercial Manufacturing Base for Car T-Cell Products in Jinshan District, Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=2611901503","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611901503?lang=en_us&edition=fundamental","pubTime":"2026-02-13 08:00","pubTimestamp":1770940835,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z81IQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0},{"id":"2606191452","title":"BRIEF-Carsgen Therapeutics Sees FY Net Loss Of Up To RMB120 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2606191452","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606191452?lang=en_us&edition=fundamental","pubTime":"2026-01-26 18:31","pubTimestamp":1769423495,"startTime":"0","endTime":"0","summary":"BRIEF-Carsgen Therapeutics Sees FY Net Loss Of Up To RMB120 MLNJan 26  - CARsgen Therapeutics Holdings Ltd 2171.HK:NET LOSS EXPECTED TO REDUCE TO UP TO RMB120 MILLION IN FYLOSS REDUCTION DUE TO INCREASED REVENUES FROM ZEVORCABTAGENE AUTOLEUCEL, OTHERS IN FYFurther company coverage: 2171.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YP06V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02171","BK1587","BK1585","BK1574"],"gpt_icon":0},{"id":"2606215670","title":"CARsgen Therapeutics Forecasts Narrower 2025 Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2606215670","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606215670?lang=en_us&edition=fundamental","pubTime":"2026-01-26 17:32","pubTimestamp":1769419937,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics  said it expects to book narrower losses in 2025, according to a Hong Kong bourse filing Monday.The firm expects a net loss of up to 120 million yuan for the year, compared with the 798 million yuan loss posted a year earlier.The company's financial results are due in early March.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1585","BK1574","BK1161","BK4007","BK4139","02171","BK1587","LENZ","BK4539"],"gpt_icon":0},{"id":"1124948915","title":"CARSGEN-B (02171) Issues Profit Warning, Anticipates 2025 Net Loss to Narrow to No More Than Approximately RMB 120 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1124948915","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124948915?lang=en_us&edition=fundamental","pubTime":"2026-01-26 17:12","pubTimestamp":1769418738,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that, based on a preliminary assessment of the Group's latest unaudited management accounts for the year ending December 31, 2025 (the reporting period), and information...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1574","BK1161","BK1587","BK1585"],"gpt_icon":0},{"id":"2606213665","title":"CARsgen Therapeutics - Net Loss Expected to Reduce to up to RMB120 Mln in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2606213665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606213665?lang=en_us&edition=fundamental","pubTime":"2026-01-26 17:01","pubTimestamp":1769418083,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YP06V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1585","BK1574","BK1161","02171","BK1587"],"gpt_icon":0},{"id":"2606136692","title":"CARsgen Therapeutics - Loss Reduction Due to Increased Revenues From Zevorcabtagene Autoleucel, Others in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2606136692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606136692?lang=en_us&edition=fundamental","pubTime":"2026-01-26 17:01","pubTimestamp":1769418083,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nFWN3YP06V:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","02171","BK1574","BK1161","BK1585"],"gpt_icon":0},{"id":"2606213504","title":"CARsgen Therapeutics forecasts sharp reduction in annual net loss for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2606213504","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606213504?lang=en_us&edition=fundamental","pubTime":"2026-01-26 17:00","pubTimestamp":1769418046,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Ltd. announced a profit alert indicating an estimated reduction in loss for the year ended December 31, 2025. Based on a preliminary assessment of unaudited management accounts, the company attributes the improved business performance in part to the commercialisation of zevorcabtagene autoleucel and the acceptance of a New Drug Application . This reflects a significant positive variation compared to previous periods, as the company anticipates a narrowed loss for the reporting year. The detailed annual results are expected to be published by early March 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL9w4W8k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1574","BK1161","02171","BK1587"],"gpt_icon":0},{"id":"2606910362","title":"CARsgen Therapeutics files HKEX disclosure for 245,000-share repurchase at HKD16.52 each","url":"https://stock-news.laohu8.com/highlight/detail?id=2606910362","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606910362?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:00","pubTimestamp":1769410811,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, confirming the repurchase of 245,000 ordinary shares at a total price of HKD 4,047,240.00, equivalent to HKD 16.5193 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on January 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL3Y5Xjb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1587","BK1585","02171","BK1161"],"gpt_icon":0},{"id":"2606255863","title":"How CARsgen’s Solid Tumor CAR T Virus Combo Trial Could Reshape Its Story for Investors (SEHK:2171)","url":"https://stock-news.laohu8.com/highlight/detail?id=2606255863","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606255863?lang=en_us&edition=fundamental","pubTime":"2026-01-25 08:39","pubTimestamp":1769301583,"startTime":"0","endTime":"0","summary":"Dispatch Bio and CARsgen Therapeutics Holdings announced a clinical collaboration to run a Phase 1 trial in China evaluating DISP-11, combining Dispatch’s Flare platform and DV-10 virus with CARsgen’s approved BCMA-targeting CAR T therapy zevorcabtagene autoleucel in patients with epithelial solid tumors.\nThis pairing of a tumor-specific virus that “paints” a synthetic antigen with an existing CAR T-cell therapy aims to open an immunotherapy path for solid tumors, where treatment options...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/how-carsgens-solid-tumor-car-t-virus-combo-trial-could-resha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/how-carsgens-solid-tumor-car-t-virus-combo-trial-could-resha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4022","BK4585","BK1574","BK1585","BK4588","BK4587","BK4551","BK4211","BK4528","BK1161","BK4230","BK4543","ISBC","02171","CAR","AI","BK4023","BK1587"],"gpt_icon":0},{"id":"1104916192","title":"CARsgen Therapeutics (02171) Announces Updates on Share Repurchases and Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104916192","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104916192?lang=en_us&edition=fundamental","pubTime":"2026-01-23 21:04","pubTimestamp":1769173458,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited (stock code: 02171) submitted a Next Day Disclosure Return on 23 January 2026, detailing changes in issued shares and treasury shares. According to the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"1198933659","title":"CARsgen Therapeutics (02171) Updates Share Repurchase Details and Changes in Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1198933659","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198933659?lang=en_us&edition=fundamental","pubTime":"2026-01-23 21:04","pubTimestamp":1769173454,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited (02171) disclosed updates on its ordinary shares, including a repurchase on 11 November 2025. The closing balance that day reached 575,086,905 issued shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"gpt_icon":0},{"id":"1111823522","title":"CARSGEN-B Surges Over 4% in Morning Session Following Recent Collaboration Announcement with Dispatch Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1111823522","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111823522?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:03","pubTimestamp":1769054587,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) saw its shares climb 4.22% in the morning session, currently trading at HK$16.31, with a turnover of HK$7.3022 million. Recently, according to an announcement on the company's...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1585","BK1161","02171","BK1587"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":0.0847},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0768},{"period":"6month","weight":-0.2583},{"period":"1year","weight":0.228},{"period":"ytd","weight":0.0519}],"compareEarnings":[{"period":"1week","weight":-0.0058},{"period":"1month","weight":-0.0065},{"period":"3month","weight":0.0473},{"period":"6month","weight":0.0424},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0305}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company mainly operates its businesses in China and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.07858},{"month":2,"riseRate":0.8,"avgChangeRate":0.24959},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"CARSGEN-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARSGEN-B,02171,CARSGEN-B股票,CARSGEN-B股票老虎,CARSGEN-B股票老虎国际,CARSGEN-B行情,CARSGEN-B股票行情,CARSGEN-B股价,CARSGEN-B股市,CARSGEN-B股票价格,CARSGEN-B股票交易,CARSGEN-B股票购买,CARSGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}